Gilead Sciences Gilead Sciences, Second Genome Partner for Microbiome-Based IBD Biomarker, Drug Discovery Second Genome will use its Microbiome Analytics platform to identify novel biomarkers linked to clinical responses to Gilead's investigational medicines. HiFiBio Bets on Single-Cell Methods to Boost Drug Discovery Premium The international firm is one of several pharmaceutical companies emphasizing new single-cell technologies to improve existing drugs and find new ones. Biocartis, Kite Sign Development Agreement for Immunotherapy Assays The agreement is part of Biocartis' long term plans to expand its presence in the oncology field by building a menu of tests for immunotherapies. Precision Medicine Master Trial Aims to Tailor Therapy for Acute Myeloid Leukemia Patients Premium The lead investigators said that Foundation Medicine's NGS test will enable the beginning of targeted treatment within seven days of diagnosis. Yale, Gilead Extend Cancer Collaboration NEW YORK (GenomeWeb) – The Yale School of Medicine today said that it and Gilead Sciences have extended a research collaboration to identify the genetic and molecular bases of cancer. Mar 12, 2013 Cancer Genetics Partners with Gilead on CLL Clinical Trials; Revises Expected Proceeds from IPO Nov 16, 2012 SomaLogic, New England Biolabs, Gilead Sue Enzymatics for IP Infringement Dec 23, 2011 UCSF Researchers ID Peptides That May Dramatically Boost HIV Infection Rates Premium Mar 30, 2011 Yale-Gilead Partnership to Investigate Genetic, Molecular Basis of Cancer Jan 7, 2011 Movers & Shakers: Jan 7, 2011 Premium Breaking News Guardant Health Files Motions to Dismiss, Change Venue in Illumina Patent Lawsuit In Brief This Week: SQI Diagnostics, T2 Biosystems, Enhanc3D, QuidelOrtho, More Illumina, Precision Health Research Singapore Partner for 100K Genomes Population Study 23andMe Fiscal Q4 Revenues Increase 14 Percent Local Coverage Determinations Roundup: Castle Bio, SkylineDx Ancient Genome Sequence Provides Look at Ancestry for Individual Who Perished at Pompeii The Scan Billion-Dollar Diversity Initiative The Howard Hughes Medical Institute is now accepting applications for its new $1.5 billion initiative to boost the diversity of the scientific workforce. Biotech Co-Founder Arrested A co-founder of a Los Angeles-based biotech company has been arrested in connection with a murder-for-hire scheme, according to Endpoint News. Return of the Tasmanian Tiger The Washington Post reports that a team in Australia is working to bring the thylacine back from extinction. Nature Papers on Genome of Individual From Pompeii, CircRNA Study Best Practices, More In Nature this week: first sequenced genome of a person from Pompeii, best practice guidelines for circRNA studies, and more.